| Code | 4534D | ||||||||||
| MA number | EU/1/14/923/005 | ||||||||||
| Product Form: | sol inj 1x0,68 ml/108 mg (striek.inj.napl.skl.v pere) | ||||||||||
| MA Status: | E - Valid centralised marketing authorisation | ||||||||||
| Type of procedure: | EU | ||||||||||
| MAH, country: | Takeda Pharma A/S, Denmark | ||||||||||
| Therapeutic Class: | 59 - IMMUNOPRAEPARATA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 24 | ||||||||||
| Route of admin.: | Subcutaneous use |
| Prescription Status: | Medicinal product subject to restricted medical prescription. |
| Legal basis: | Article 8(3) application - new active substance |
| MA issued: | 22.05.2014 |
| SmPC + PL: |
European Medicines Agency's database
|
| Dokument: |
Entyvio_Príručka pre lekára.pdf
|
| Safety feature | Yes |
| Data update: | 21.02.2024 |
